111 related articles for article (PubMed ID: 9096692)
21. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
22. Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia.
Bram S; Swolin B; Rödjer S; Stockelberg D; Ogärd I; Bäck H
Cancer Genet Cytogenet; 2003 Apr; 142(2):107-14. PubMed ID: 12699885
[TBL] [Abstract][Full Text] [Related]
23. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
Boultwood J; Rack K; Kelly S; Madden J; Sakaguchi AY; Wang LM; Oscier DG; Buckle VJ; Wainscoat JS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6176-80. PubMed ID: 1829836
[TBL] [Abstract][Full Text] [Related]
24. Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study.
Cherry AM; Brockman SR; Paternoster SF; Hicks GA; Neuberg D; Higgins RR; Bennett JM; Greenberg PL; Miller K; Tallman MS; Rowe J; Dewald GW
Leuk Res; 2003 Dec; 27(12):1085-90. PubMed ID: 12921944
[TBL] [Abstract][Full Text] [Related]
25. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.
Yilmaz Z; Sahin FI; Kizilkilic E; Karakus S; Boga C; Ozdogu H
Clin Exp Med; 2005 Jul; 5(2):55-9. PubMed ID: 16096854
[TBL] [Abstract][Full Text] [Related]
26. Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens.
Jenkins RB; Le Beau MM; Kraker WJ; Borell TJ; Stalboerger PG; Davis EM; Penland L; Fernald A; Espinosa R; Schaid DJ
Blood; 1992 Jun; 79(12):3307-15. PubMed ID: 1596571
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level.
Nilsson L; Astrand-Grundström I; Arvidsson I; Jacobsson B; Hellström-Lindberg E; Hast R; Jacobsen SE
Blood; 2000 Sep; 96(6):2012-21. PubMed ID: 10979941
[TBL] [Abstract][Full Text] [Related]
28. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
29. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes.
Flactif M; Lai JL; Preudhomme C; Fenaux P
Leukemia; 1994 Jun; 8(6):1012-8. PubMed ID: 8207974
[TBL] [Abstract][Full Text] [Related]
31. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias.
Brizard F; Brizard A; Guilhot F; Tanzer J; Berger R
Leukemia; 1994 Jun; 8(6):1005-11. PubMed ID: 8207973
[TBL] [Abstract][Full Text] [Related]
32. [Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].
Shen Y; Xue Y; Li J; Pan J; Wu Y; Chen S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):160-3. PubMed ID: 12673589
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
[TBL] [Abstract][Full Text] [Related]
34. Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH.
Ketterling RP; Wyatt WA; VanWier SA; Law M; Hodnefield JM; Hanson CA; Dewald GW
Leuk Res; 2002 Mar; 26(3):235-40. PubMed ID: 11792411
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence in situ hybridization for del(5q) in myelodysplasia/acute myeloid leukemia: comparison of EGR1 vs. CSF1R probes and diagnostic yield over metaphase cytogenetics alone.
Sun Y; Cook JR
Leuk Res; 2010 Mar; 34(3):340-3. PubMed ID: 19608274
[TBL] [Abstract][Full Text] [Related]
36. Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions.
Kroef MJ; Fibbe WE; Mout R; Jansen RP; Haak HL; Wessels JW; Van Kamp H; Willemze R; Landegent JE
Blood; 1993 Apr; 81(7):1849-54. PubMed ID: 8461471
[TBL] [Abstract][Full Text] [Related]
37. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
Lopez-Villar O; Garcia JL; Sanchez-Guijo FM; Robledo C; Villaron EM; Hernández-Campo P; Lopez-Holgado N; Diez-Campelo M; Barbado MV; Perez-Simon JA; Hernández-Rivas JM; San-Miguel JF; del Cañizo MC
Leukemia; 2009 Apr; 23(4):664-72. PubMed ID: 19151777
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence in situ hybridization for the study of cell lineage involvement in myelodysplastic syndromes with chromosome 5 anomalies.
Anderson K; Arvidsson I; Jacobsson B; Hast R
Cancer Genet Cytogenet; 2002 Jul; 136(2):101-7. PubMed ID: 12237232
[TBL] [Abstract][Full Text] [Related]
39. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
40. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]